Extendicare's book value per share for the quarter that ended in Mar. 2026 was $3.02.
During the past 12 months, Extendicare's average Book Value Per Share Growth Rate was 177.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 49.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 17.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 0.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Extendicare was 82.00% per year. The lowest was -128.90% per year. And the median was -2.80% per year.
Extendicare's current price is $25.78. Its book value per share for the quarter that ended in Mar. 2026 was $3.02. Hence, today's PB Ratio of Extendicare is 8.53.
During the past 13 years, the highest P/B Ratio of Extendicare was 11.44. The lowest was 3.73. And the median was 5.98.
Extendicare (OTCPK:EXETF) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Extendicare Book Value per Share Related Terms
Extendicare Book Value per Share Historical Data
* Premium members only.
The historical data trend for Extendicare's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EXETF vs HCA, THC, DVA: Book Value per Share Comparison
For the Medical Care Facilities subindustry, Extendicare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Extendicare's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extendicare (EXETF) has a Book Value per Share of $3.02 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Extendicare and its competitors.
Is Extendicare's Book Value per Share too high?
Extendicare's current Book Value per Share is $3.02. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Book Value per Share compare to HCA and THC?
Extendicare's Book Value per Share of $3.02 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Healthcare Providers & Services company?
A good Book Value per Share depends on the Healthcare Providers & Services industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Extendicare and its competitors. Extendicare's current Book Value per Share is $3.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.68, compared to a current price of $25.78 — trading 166.3% above its estimated fair value. The current Book Value per Share is $3.02. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Extendicare (EXETF), the current Book Value per Share is $3.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $25.78 is trading 166.3% above its estimated GF Value™ of $9.68.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
Book Value per Share: $3.02
GF Value™: $9.68 vs. price of $25.78 (166.3% above fair value)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score
Get the complete analysis for EXETF
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 
